Structure via PubChem · Public domain (PubChem)
Riluzol
Sign in to saveRiluzole is a medication used to treat amyotrophic lateral sclerosis (ALS) and other motor neuron diseases. Riluzole delays the onset of ventilator-dependence or tracheostomy in some people and may increase survival by two to three months. Riluzole is available in tablet and liquid form. A thin film version of riluzole which dissolves on the tongue (commercially known as Exservan or Emylif) is available in the United States and United Kingdom.
In the Vinony graph
Within Vinony's link graph, Riluzol is referenced by 547 other articles, and connects out to ginkgolide, γ-aminobutyric acid and valproic acid.
Vinony files it under Benzothiazoles, Drugs with non-standard legal status and Drugs with unknown mechanisms of action.
Its subject is documented across 26 Wikipedia language editions.
Chemical data
- Formula
- C8H5F3N2OS
- Molecular weight
- 234.2 g/mol
- IUPAC name
- 6-(trifluoromethoxy)-1,3-benzothiazol-2-amine
- SMILES
- C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N
- InChIKey
- FTALBRSUTCGOEG-UHFFFAOYSA-N
- XLogP
- 3.6
- Polar surface area
- 76.4 Ų
- H-bond donors
- 1
- H-bond acceptors
- 7
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 1995
- Admin. routes
- oral
- Indications
- post-traumatic stress disorder, autism spectrum disorder, cutaneous melanoma, obsessive-compulsive disorder
via ChEMBL · EBI
Research
2,265 papers- Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).The Cochrane database of systematic reviews · 2012
- The pharmacology and mechanism of action of riluzole.Neurology · 1996
- Riluzole for the treatment of amyotrophic lateral sclerosis.Neurodegenerative disease management · 2020
- A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group.The New England journal of medicine · 1994
- Riluzole.Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases · 2000
via PubMed
Wikidata facts
- Mass
- 234.007468
- Has use
- medication
Show 5 more facts
- chemical formula
- C₈H₅F₃N₂OS
- medical condition treated
- ALS
- canonical SMILES
- C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N
- defined daily dose
- 0.1
- Commons category
- Riluzole
Sources (8)
via Wikidata · CC0
Article · Svenska
Riluzol (marknadsnamn Rilutek®) är ett läkemedel för att förlänga överlevnaden hos ALS-patienter som fortfarande kan andas själva. Exakt hur riluzol fungerar är inte klart, troligen hämmar det glutmatprocesser i nervsystemet. Glutamat är den vanligaste neuroexcitatoriska ämnet i nervsystemet och man tror att den kan vara inblandad i döden av neuron som sker vid ALS. Denna läkemedels- eller farmakologi-relaterade artikel saknar väsentlig information. Du kan hjälpa till genom att lägga till den.
Abstract from DBpedia / Wikipedia · CC BY-SA